Assessment of the Efficacy, Tolerability and Pharmaco-economic Impact of Zoledronic Acid Treatment in Prostate Cancer With Bone Metastasis

Status:
Completed

Trial end date:
1969-12-31

Target enrollment:

Participant gender:

Study to determine effectiveness and safety of zoledronic acid and whether it has a pharmaco-economic impact in prostate cancer with bone metastasis.

Phase 4

Novartis Pharmaceuticals

Diphosphonates
Zoledronic Acid